WAY-643895 is a casein kinase 1δ (CK1δ) inhibitor with >5% inhibition. It can be used in studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-643895 is a casein kinase 1δ (CK1δ) inhibitor with >5% inhibition. It can be used in studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-643895 is a casein kinase 1δ (CK1δ) inhibitor with >5% inhibition. It can be used in studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-643895 is a casein kinase 1δ (CK1δ) inhibitor with >5% inhibition. It can be used in studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-643895 is a casein kinase 1δ (CK1δ) inhibitor with >5% inhibition. It can be used in studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-647766 is a potent Casein kinase 1δ inhibitor for Alzheimer's disease related studies.
WAY-647766 is a potent Casein kinase 1δ inhibitor for Alzheimer's disease related studies.
WAY-652509 is a potent casein kinase 1δ (CK1δ/CK15) inhibitor for studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-652509 is a potent casein kinase 1δ (CK1δ/CK15) inhibitor for studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-652509 is a potent casein kinase 1δ (CK1δ/CK15) inhibitor for studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-652509 is a potent casein kinase 1δ (CK1δ/CK15) inhibitor for studies related to neurodegenerative diseases such as Alzheimer's disease.
WAY-652848 is a selective inhibitor of SRPK1 with an IC50 value of 0.58 μM.WAY-652848 effectively reduces choroidal neovascularization (CNV) in vivo, and can be used in the study of age-related macular degeneration.